(Q53863305)

21 May 2018

title

Subcutaneously administered efalizumab (anti-CD11a) improves signs and symptoms of moderate to severe plaque psoriasis. (English)

1 reference

21 May 2018

author name string

Alice B Gottlieb

1

1 reference

21 May 2018

Bruce Miller

2

1 reference

21 May 2018

Nicholas Lowe

3

1 reference

21 May 2018

William Shapiro

4

1 reference

21 May 2018

Charles Hudson

5

1 reference

21 May 2018

Ross Bright

6

1 reference

21 May 2018

Mark Ling

7

1 reference

21 May 2018

Anna Magee

8

1 reference

21 May 2018

Calvin O McCall

9

1 reference

21 May 2018

Toivo Rist

10

1 reference

21 May 2018

Wolfgang Dummer

11

1 reference

21 May 2018

Patricia Walicke

12

1 reference

21 May 2018

Robert J Bauer

13

1 reference

21 May 2018

Mark White

14

1 reference

21 May 2018

Marvin Garovoy

15

1 reference

21 May 2018

publication date

1 May 2003

1 reference

21 May 2018

Journal of cutaneous medicine and surgery

published in

1 reference

21 May 2018

volume

7

1 reference

21 May 2018

issue

3

1 reference

21 May 2018

page(s)

198-207

1 reference

21 May 2018

Use of cyclosporin in psoriasis

cites work

1 reference

https://api.crossref.org/works/10.1177%2F120347540300700303

Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F120347540300700303

Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F120347540300700303

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F120347540300700303

Lymphocyte migration into tissue: the paradigm derived from CD4 subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F120347540300700303

The immunological synapse: a molecular machine controlling T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F120347540300700303

The role of adhesion molecules, chemotactic factors, and cytokines in inflammatory and neoplastic skin disease--1990 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F120347540300700303

Anti-CD11a ameliorates disease in the human psoriatic skin-SCID mouse transplant model: comparison of antibody to CD11a with Cyclosporin A and clobetasol propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F120347540300700303

The relevance of murine animal models to study the development of allergic bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F120347540300700303

Long-term survival of solid organ allografts by brief anti-lymphocyte function-associated antigen-1 monoclonal antibody monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F120347540300700303

Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F120347540300700303

Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F120347540300700303

10.1177/120347540300700303

21 January 2018

Identifiers

DOI

1 reference

21 May 2018

1 reference

21 May 2018